Mayo Clinic strategic transactions and intellectual property have been instrumental to the creation and success of numerous collaborations, exclusive agreements, start-up companies, business ventures and equity investments.
Below is a small sampling.
Impact stories
Phage therapy treatment
Using viruses to target and kill specific bacteria
Read case study
Evolving vaccine efforts
Single-cycle adenovirus vaccine platform
Read case study
Cancer screening revolution
FDA-approved noninvasive colorectal screening
Read case study
Remote ECG patient monitoring
Mayo Clinic IP paves way for FDA-cleared remote heart monitoring device
Read case study
Magnetic Resonance Elastography
Revolutionary imaging tool for diagnosing liver fibrosis
Read case study
Innovation Spotlight
Imaging technology begins with something called a reporter gene. In Dr. Peng’s system, a human protein called sodium-iodide symporter, or NIS, fulfills this role. Iodine — or radioactive iodine tracer — can accumulate in tissues if the cells there have been engineered to express NIS. While light from fluorescent and luminescent reporters is too weak to shine through layers of tissue, the electromagnetic radiation arising from iodine tracers penetrates readily.
Content displayed is subject to change.